Peters R M, Swain J A
Am J Surg. 1982 Jun;143(6):701-5. doi: 10.1016/0002-9610(82)90040-x.
Coronary artery disease, emphysema, and lung cancer often occur together and have cigarette smoking as a common etiologic contributor. The management of the patient with lung cancer, coronary artery disease, and emphysema is complex. The patient with significant coronary artery disease should undergo coronary artery bypass before or concurrently with pulmonary resection. Only proven carcinomas should be resected at the time of coronary artery bypass grafting because immunosuppression secondary to cardiopulmonary bypass can result in the life-threatening spread of fungal or other infections if biopsy is performed at the time of cardiopulmonary bypass. The risk of pulmonary resection is increased in the patient with emphysema because of decreased efficiency of the lungs and chest wall. Likewise, emphysema results in greater risk in the patient with coronary artery disease because of increased demands on the heart.
冠状动脉疾病、肺气肿和肺癌常同时发生,吸烟是它们共同的病因。肺癌、冠状动脉疾病和肺气肿患者的治疗很复杂。患有严重冠状动脉疾病的患者应在肺切除术前或同时进行冠状动脉搭桥手术。在进行冠状动脉搭桥手术时,仅应切除已确诊的癌肿,因为体外循环继发的免疫抑制会导致真菌或其他感染的危及生命的扩散,如果在体外循环时进行活检的话。由于肺和胸壁效率降低,肺气肿患者进行肺切除的风险增加。同样,由于心脏负担增加,肺气肿会给冠状动脉疾病患者带来更大风险。